About 500 Mg 50 Ml Rituximab
Experience grand precision in oncology and rheumatology care with 500 mg/50 ml Rituximab injection. Capitalise on instant checkout opportunities for bulk and clearance orders from leading distributors, exporters, and suppliers across India. Packaged in a sterling glass vial with a flip-off seal, this genetically engineered, preservative-free monoclonal antibody offers a grandiose solution targeting B lymphocytes. Each clear to pale yellow solution delivers 10 mg/ml Rituximab for intravenous use, approved by DCGI/CDSCO. Monitor patients for infusion reactions; storage at 2-8C ensures potency for 24 months. Barcode and batch details printed for traceability.
Applications and Features of Rituximab 500 mg/50 ml
Indicated for Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis, Rituximab's grandiose efficacy is realised through intravenous application. Its sterile, preservative-free nature, and compatibility with saline and 5% dextrose mark distinctive features. To prepare, the solution requires dilution, ensuring safe infusion per medical guidance. Its unique enzymatic activity targets the CD20 antigen on B lymphocytes. The clear, pale yellow vial is a symbol of impeccable quality and precise genetic engineering, designed for optimal therapeutic results.
Sterling Export Markets and Supreme Domestic Distribution
Rituximab 500 mg/50 ml sees quick dispatch and reliable shipped goods to grand export markets in Asia, Africa, and other international territories. On the domestic mar, the product is available through premium distributors and traders with flexible payment terms, catering to hospitals, clinics, and pharmacies. Instant checkout and bulk order options make procurement seamless for both domestic and global clients, ensuring continuous availability and timely delivery tailored for the pharmaceutical industry.
FAQ's of 500 Mg 50 Ml Rituximab:
Q: How is 500 mg/50 ml Rituximab administered?
A: Rituximab is administered intravenously after dilution with compatible solutions such as saline or 5% dextrose, and should be given under qualified medical supervision.
Q: What storage conditions are required for Rituximab?
A: Store the glass vial between 2-8C, do not freeze, and protect it from light to maintain efficacy and shelf life up to 24 months.
Q: When should Rituximab not be used?
A: Rituximab should not be used in patients with known hypersensitivity to Rituximab or those who have experienced mortal anaphylaxis to this therapy.
Q: Where can Rituximab 500 mg/50 ml be exported and supplied?
A: Rituximab is exported and supplied through reputable distributors to markets in Asia, Africa, and within India's domestic pharmaceutical sector.
Q: What are the key benefits of Rituximab therapy?
A: Rituximab targets CD20 antigens on B lymphocytes, supporting the treatment of certain cancers and autoimmune disorders, with proven regulatory approval and safety standards.
Q: How should patients be monitored when receiving Rituximab?
A: Patients should be closely observed for infusion reactions and signs of infection throughout and after the intravenous infusion process.